NEW YORK – Thermo Fisher Scientific said on Thursday that on April 17, it entered into a bridge credit agreement with JPMorgan Chase and Morgan Stanley Senior Funding for up to €9.25 billion ($9.96 billion).
The company had announced on March 3 that the lenders had committed to the debt financing in connection with its proposed acquisition of Qiagen.
Under the terms of the agreement, Thermo Fisher is obtaining a 364-day senior unsecured bridge loan facility in the principal amount of up to €9.25 billion. Loans under the agreement will be available to fund the purchase of equity securities of Qiagen and to pay all or a portion of the cost incurred in connection with this.
Thermo Fisher can draw on the funds on the closing date of the acquisition and again within 120 days after the closing date.